NEUROCRINE BIOSCIENCES INC Quarterly Current Ratio in % from Q1 2012 to Q2 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Neurocrine Biosciences Inc quarterly Current Ratio history and growth rate from Q1 2012 to Q2 2024.
  • Neurocrine Biosciences Inc Current Ratio for the quarter ending June 30, 2024 was 274 %, a 3.07% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 274 -8.68 -3.07% Jun 30, 2024
Q1 2024 248 -55.7 -18.3% Mar 31, 2024
Q4 2023 269 -32.1 -10.7% Dec 31, 2023
Q3 2023 276 -55.9 -16.9% Sep 30, 2023
Q2 2023 282 -115 -28.9% Jun 30, 2023
Q1 2023 304 -134 -30.6% Mar 31, 2023
Q4 2022 301 -177 -37% Dec 31, 2022
Q3 2022 332 -185 -35.8% Sep 30, 2022
Q2 2022 397 +33.3 +9.16% Jun 30, 2022
Q1 2022 438 +156 +55.1% Mar 31, 2022
Q4 2021 477 +193 +68.2% Dec 31, 2021
Q3 2021 517 +300 +138% Sep 30, 2021
Q2 2021 364 +93.9 +34.8% Jun 30, 2021
Q1 2021 282 -83 -22.7% Mar 31, 2021
Q4 2020 284 -71.5 -20.1% Dec 31, 2020
Q3 2020 217 -564 -72.2% Sep 30, 2020
Q2 2020 270 -125 -31.7% Jun 30, 2020
Q1 2020 365 -25.8 -6.6% Mar 31, 2020
Q4 2019 355 -32.8 -8.46% Dec 31, 2019
Q3 2019 781 +401 +106% Sep 30, 2019
Q2 2019 395 -693 -63.7% Jun 30, 2019
Q1 2019 391 -901 -69.7% Mar 31, 2019
Q4 2018 388 -919 -70.3% Dec 31, 2018
Q3 2018 380 -985 -72.2% Sep 30, 2018
Q2 2018 1.09K -245 -18.4% Jun 30, 2018
Q1 2018 1.29K +83.1 +6.87% Mar 31, 2018
Q4 2017 1.31K -55.8 -4.1% Dec 31, 2017
Q3 2017 1.36K -132 -8.83% Sep 30, 2017
Q2 2017 1.33K -297 -18.2% Jun 30, 2017
Q1 2017 1.21K -595 -33% Mar 31, 2017
Q4 2016 1.36K -632 -31.7% Dec 31, 2016
Q3 2016 1.5K -519 -25.8% Sep 30, 2016
Q2 2016 1.63K -254 -13.5% Jun 30, 2016
Q1 2016 1.8K +74.2 +4.29% Mar 31, 2016
Q4 2015 1.99K +464 +30.3% Dec 31, 2015
Q3 2015 2.02K +463 +29.8% Sep 30, 2015
Q2 2015 1.88K +359 +23.6% Jun 30, 2015
Q1 2015 1.73K +364 +26.7% Mar 31, 2015
Q4 2014 1.53K +363 +31.1% Dec 31, 2014
Q3 2014 1.55K +395 +34.1% Sep 30, 2014
Q2 2014 1.52K +508 +49.9% Jun 30, 2014
Q1 2014 1.37K +498 +57.5% Mar 31, 2014
Q4 2013 1.17K +465 +66.3% Dec 31, 2013
Q3 2013 1.16K +660 +133% Sep 30, 2013
Q2 2013 1.02K +624 +158% Jun 30, 2013
Q1 2013 867 +552 +175% Mar 31, 2013
Q4 2012 702 Dec 31, 2012
Q3 2012 498 Sep 30, 2012
Q2 2012 393 Jun 30, 2012
Q1 2012 315 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.